# Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients

> **NCT03587415** · — · COMPLETED · sponsor: **Recep Tayyip Erdogan University Training and Research Hospital** · enrollment: 80 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** preptin and amylin level

## Key facts

- **NCT ID:** NCT03587415
- **Lead sponsor:** Recep Tayyip Erdogan University Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-28
- **Primary completion:** 2017-11-30
- **Final completion:** 2017-12-07
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2018-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03587415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03587415, "Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03587415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*